86 results
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
15 May 24
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:15pm
trials, supply chain, operations and the operations of third parties we rely on for services such as manufacturing, marketing support and sales support
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
9 Apr 24
Results of Operations and Financial Condition
8:30am
ability to obtain and maintain intellectual property protection for Twirla and our product candidates, clinical trials, supply chain, operations
8-K
EX-99.1
bpv4 27j3n48l
28 Mar 24
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
9:06am
8-K
EX-99.1
roplceo4kfcg0
9 Nov 23
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
8:15am
8-K
EX-99.1
brh7t621nxyw
9 Aug 23
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8:10am
8-K
inqw l7uo
30 Jun 23
Departure of Directors or Certain Officers
4:50pm
424B4
d19hms6 3f32upzh
24 May 23
Prospectus supplement with pricing info
4:05pm
8-K
EX-99.1
by51286vh08szqao
11 May 23
Agile Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:15pm
8-K
12brb60
28 Apr 23
Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023
4:40pm